Roxbury Financial »

Summit Therapeutics shares owned by Roxbury Financial

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Roxbury Financial from 13F filings

Historical chart of Roxbury Financial investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Roxbury Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Roxbury Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.9k 187 20.66

More positions owned by Roxbury Financial

Microsoft Corp Stock (MSFT)
Fidelity Blue Chip Growth Etf Etf (FBCG)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Visa Inc Com Cl A Stock (V)
Fidelity Nasdaq Composite Index Etf Etf (ONEQ)
Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Amazon Stock (AMZN)
Fidelity Msci Consumer Staples Index Etf Etf (FSTA)
Jpmorgan Chase & Co Stock (JPM)
Wells Fargo Stock (WFC)
International Business Machs Stock (IBM)
Walmart Stock (WMT)
Mckesson Corp Stock (MCK)
Fidelity Msci Health Care Index Etf Etf (FHLC)

View all positions for Roxbury Financial

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics